TB-500 (Thymosin Beta-4) 10mg Tissue Repair | Recovery & Regeneration Research Peptide

TB-500 (Thymosin Beta-4) 10mg Tissue Repair | Recovery & Regeneration Research Peptide

Overview TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4) — a naturally occurring 43-amino acid regulatory peptide identified in nearly every human cell, with particularly high concentrations in platelets and wound fluid. The 10mg presentation is engineered for advanced research into tissue repair, cellular migration, and systemic recovery mechanisms.

Mechanism of Interest Thymosin Beta-4 is one of the most extensively studied peptides in regenerative biology, recognised for its role in actin sequestration — the process governing cytoskeletal remodelling, cell migration, and structural repair. Research has explored its influence across angiogenesis, endothelial cell differentiation, inflammation modulation, fibrosis pathways, and recruitment of progenitor cells to sites of injury. Its compact active region (often referenced as the "TB-500 fragment") allows for efficient distribution and stability across research models.

Product Specifications

• Product Name: TB-500 (Thymosin Beta-4 Fragment) 10mg
• Catalogue Reference: TB5-024
• Sequence: Ac-LKKTETQ
• Molecular Formula: C₃₈H₆₈N₉O₁₄ (acetylated heptapeptide fragment)
• Molecular Weight: ~889 g/mol
• Purity: ≥98% (HPLC verified)
• Presentation: Lyophilised solid
• Storage: -20°C

Research Applications TB-500 is widely utilised in research across musculoskeletal repair, soft-tissue regeneration, cardiovascular models, dermal healing, and recovery science. Its systemic distribution profile and influence on cell migration make it a refined tool for studies investigating injury models, post-trauma recovery pathways, fibrotic remodelling, and connective tissue biology — particularly in models exploring tendon, ligament, and muscle restoration.

Synergistic Research Context TB-500 is frequently studied alongside BPC-157 in dual-peptide research models — where TB-500's systemic, migration-driven action complements BPC-157's localised cytoprotective and angiogenic profile. This pairing is one of the most extensively explored combinations in regenerative peptide research.

Quality & Handling Synthesised under controlled laboratory conditions and supplied as a lyophilised solid for maximum stability. Reconstitution with appropriate bacteriostatic solution is required prior to use in any research model. Every batch is subjected to rigorous quality control to ensure purity, identity, and batch-to-batch consistency.

Compliance Statement All Asclepius peptide products are supplied strictly for laboratory research purposes. They are not intended for human consumption, diagnosis, treatment, or therapeutic use. Enquiries relating to human application cannot be supported.

Order with Confidence Asclepius peptides are sourced, tested, and dispatched to a clinical standard — built for researchers and practitioners who refuse to compromise on integrity, purity, or precision.

For technical specifications, certificates of analysis, or research support, our team is available to assist.